ResMed
From Wikipedia, the free encyclopedia
| ResMed | |
 |
|
| Type | Public (NYSE: RMD) |
|---|---|
| Founded | 1989 |
| Headquarters | Poway, California |
| Key people | Peter C. Farrell, Founder and CEO |
| Industry | Medical |
| Products | Medical equipment for sleep-disordered breathing and other respiratory disorders |
| Website | www.resmed.com |
ResMed is a manufacturer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and obstructive sleep apnea (OSA).
When ResMed was formed in 1989, its primary purpose was to commercialize a device for treating OSA. Developed in 1981 by Professor Colin Sullivan at the University of Sydney, nasal continuous positive airway pressure (CPAP) provided the first successful noninvasive treatment of OSA. Since 1989, ResMed has maintained its focus on SDB, which is gaining greater public and physician awareness.
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
